MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Peripheral Blood Mononuclear Cells (PBMCs) are Useful Biomarkers of Mitochondrial Dysfunction in Parkinson Disease Patients with Pathogenic Parkin and LRRK2 Mutations

    P. Campbell, J. Harvey, A. Costantini, H. Morris, A. Schapira (London, United Kingdom)

    Objective: To investigate the use of PBMCs as a biomarker of mitochondrial dysfunction in Parkinson disease (PD) patients carrying pathogenic parkin or LRRK2 mutations. Background:…
  • 2019 International Congress

    Genomic variants associated with cognitive impairment in Parkinson’s disease: Ethnicity-specific GWAS

    SJ. Chung, N. Choi, J. Kim, K. Kim, MJ. Kim, YJ. Kim, HS. Ryu, KW. Park (Anyang, Republic of Korea)

    Objective: We aimed to identify the genomic variants that are associated with cognitive impairment in patients with Parkinson’s disease (PD). Background: Cognitive impairment is an…
  • 2019 International Congress

    Characteristics of African American Parkinson’s Disease patients seen in a Large Clinic Practice

    M. Dean, M. Patel, K. Barnes, D. Standaert (Birmingham, AL, USA)

    Objective: To describe and compare characteristics of African American (AA) and White Parkinson’s Disease (PD) patients seen in a large clinic practice at the University…
  • 2019 International Congress

    Pattern and Presentation of Parkinson Disease in two Teaching Hospitals in Enugu, South East Nigeria

    B. Ezeala-Adikaibe (Enugu, Nigeria)

    Objective: To describe the pattern of presentation of Parkinson disease in patients attending medical out-patient clinic in Enugu South East Nigeria. Background: Parkinson Disease is…
  • 2019 International Congress

    DBS Programming In Tremor And Akinetic-Rigid Predominant Parkinson’s Disease

    Z. Guduru, D. Ginjupally, T. Ali, N. El Seblani, J. Quintero, C. van Horne (Lexington, KY, USA)

    Objective: Deep brain stimulation (DBS) targeting Globus pallidus pars interna (GPi) and subthalamic nucleus (STN) is an established surgical treatment for Parkinson’s disease (PD). Due…
  • 2019 International Congress

    Relationship between intestinal bacteria, bacterial metabolites and residual pesticides in Parkinson’s disease

    M. Hirayama, T. Hamaguchi, M. Ito, T. Ishida, M. Kuki, T. Maeda, K. Kashihara, Y. Tsuboi, K. Ohno (Hukuoka, Japan)

    Objective: We examined the relationship between intestinal bacteria, oral bacteria, bacterial metabolites, residual pesticides and clinical symptoms. Background: Intestinal environment is thought to be involved…
  • 2019 International Congress

    Applicability of modified definition of Vascular Parkinsonism in patients with Parkinsonism attending outpatient department: A tertiary care hospital-based study in south India

    S. Jaiswal (Hyderabad, India)

    Objective: This study aims to assess the applicability of modified Vascular Parkinsonism (VP) criteria in outpatient department in a tertiary care hospital in south India.…
  • 2019 International Congress

    Attitude of Parkinson Patients towards Participation in Clinical Trials and Brain or Tissue Donation for Research

    S. Khan, J. Foo, N. Chia, S. Agustin, S. Neo, T. Yaw, A. Lok, A. Ng, L. Tan (Singapore, Singapore)

    Objective: A comprehensive survey of patient preferences and attitudes towards clinical trials and tissue donation can help identify and address barriers hindering the recruitment for…
  • 2019 International Congress

    Speech and language changes in cognitive impairment subtypes in patients with Parkinson´s disease

    A. Kušnírová, Z. Košutzká, M. Hajdúk, M. Králová, M. Pápayová, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)

    Objective: The aim of our study was to compare speech (intelligibility and comprehensibility) and language (lexical-semantic aspect) abilities with cognitive profiles in patients with Parkinson´s…
  • 2019 International Congress

    Correlation Between PDQ-39 and MDS-UPDRS Scores in a Phase 3 Randomized Controlled Trial of Patients with Parkinson’s Disease

    T. Lokhandwala, A. Lee, B. Yue, A. Thach, B. Navia (Palm Harbor, FL, USA)

    Objective: To describe correlations of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) part III scores with the 39-item Parkinson’s disease (PD) questionnaire…
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley